S&P Capital IQ Picks AGN Focus Stock of the Week

Mon Jan 7, 2013 1:15pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link


NEW YORK,  Jan. 7, 2013  /PRNewswire/ -- Allergan Inc. (NYSE: AGN  $98) has been
picked by S&P Capital IQ as its Focus Stock of the Week. AGN carries S&P Capital
IQ's highest investment recommendation of 5-STARS, or Strong Buy.

"We see solid growth prospects in Allergan's core Botox and ophthalmic
pharmaceutical franchises, and an advancing pipeline that we expect to spawn
multiple drivers over the coming years," said  Herman Saftlas, equity analyst at
S&P Capital IQ.  "Unlike many big pharma players, we believe that most of the
company's key franchises are valued proprietary brands with limited generic

About S&P Capital IQ  
S&P Capital IQ, a business line of the McGraw-Hill Companies (NYSE:MHP), is a
leading provider of multi-asset class and real time data, research and analytics
to institutional investors, investment and commercial banks, investment advisors
and wealth managers, corporations and universities around the world. We provide
a broad suite of capabilities designed to help track performance, generate
alpha, identify new trading and investment ideas, and perform risk analysis and
mitigation strategies. Through leading desktop solutions such as Capital IQ,
Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such
as S&P Valuations, and Compustat; and research offerings, including Leveraged
Commentary & Data, Global Market Intelligence, and company and fund research,
S&P Capital IQ sharpens financial intelligence into the wisdom today's investors
need.  For more information visit  www.spcapitaliq.com.  

All information provided by S&P Capital IQ is impersonal and not tailored to the
needs of any person, entity or group of persons.  Past performance is no
indication of future results. S&P Capital IQ and its affiliates provide a wide
range of services to, or relating to, many organizations, including issuers of
securities, investment advisers, broker-dealers, investment banks, other
financial institutions and financial intermediaries, and accordingly may receive
fees or other economic benefits from those organizations, including
organizations whose securities or services they may recommend, rate, include in
model portfolios, evaluate or otherwise address.

This material is not intended as an offer or solicitation for the purchase or
sale of any security or other financial instrument. Securities, financial
instruments or strategies mentioned herein may not be suitable for all
investors. Any opinions expressed herein are given in good faith, are subject to
change without notice, and are only current as of the stated date of their
issue. Prices, values, or income from any securities or investments mentioned in
this report may fall against the interests of the investor and the investor may
get back less than the amount invested. Where an investment is described as
being likely to yield income, please note that the amount of income that the
investor will receive from such an investment may fluctuate. Where an investment
or security is denominated in a different currency to the investor's currency of
reference, changes in rates of exchange may have an adverse effect on the value,
price or income of or from that investment to the investor. The information
contained in this report does not constitute advice on the tax consequences of
making any particular investment decision. This material does not take into
account your particular investment objectives, financial situations or needs and
is not intended as a recommendation of particular securities, financial
instruments or strategies to you nor is it considered to be investment advice.
Before acting on any recommendation in this material, you should consider
whether it is suitable for your particular circumstances and, if necessary, seek
professional advice.

This material is based upon information that we consider to be reliable, but
neither S&P Capital IQ nor its affiliates warrant its completeness, accuracy or
adequacy and it should not be relied upon as such. With respect to reports
issued to clients in a language other than English and in the case of
inconsistencies between the English and translated versions of a report, the
English version prevails. Neither S&P Capital IQ nor its affiliates guarantee
the accuracy of the translation. Assumptions, opinions and estimates constitute
our judgment as of the date of this material and are subject to change without
notice. Neither S&P Capital IQ nor its affiliates are responsible for any errors
or omissions or for results obtained from the use of this information. Past
performance is not necessarily indicative of future results.

SOURCE  S&P Capital IQ

Marc Eiger, Communications, +1-212-438-1280, marc_eiger@spcapitaliq.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.